Epigenetic biomarkers in cancer epidemiology
- PMID: 22359311
- DOI: 10.1007/978-1-61779-612-8_28
Epigenetic biomarkers in cancer epidemiology
Abstract
Biochemical, epigenetic, genetic, and imaging biomarkers are used to identify people at high risk for developing cancer. In cancer epidemiology, epigenetic biomarkers offer advantages over other types of biomarkers because they are expressed against a person's genetic background and environmental exposure, and because epigenetic events occur early in cancer development. This chapter describes epigenetic biomarkers that are being used to study the epidemiology of different types of cancer. Because epigenetic alterations can be reversed by chemicals and activate gene expression, epigenetic biomarkers potentially have numerous clinical applications in cancer intervention and treatment and significant implications in public health. This review discusses cancer biomarkers, the characteristics of an ideal biomarker for cancer, and technologies for biomarker detection.
Similar articles
-
Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation.Methods Mol Biol. 2012;863:439-65. doi: 10.1007/978-1-61779-612-8_27. Methods Mol Biol. 2012. PMID: 22359310 Review.
-
Epigenetic targets in cancer epidemiology.Methods Mol Biol. 2009;471:457-67. doi: 10.1007/978-1-59745-416-2_23. Methods Mol Biol. 2009. PMID: 19109794
-
Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.Toxicol Mech Methods. 2011 May;21(4):289-97. doi: 10.3109/15376516.2011.557881. Toxicol Mech Methods. 2011. PMID: 21495867 Review.
-
Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.Methods Mol Biol. 2012;863:221-39. doi: 10.1007/978-1-61779-612-8_13. Methods Mol Biol. 2012. PMID: 22359296 Review.
-
Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.Crit Rev Oncol Hematol. 2006 Oct;60(1):9-18. doi: 10.1016/j.critrevonc.2006.04.002. Epub 2006 Jul 10. Crit Rev Oncol Hematol. 2006. PMID: 16829121 Review.
Cited by
-
DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.Dis Markers. 2017;2017:5472893. doi: 10.1155/2017/5472893. Epub 2017 Sep 6. Dis Markers. 2017. PMID: 29038614 Free PMC article. Review.
-
DNA methylation markers for oral pre-cancer progression: A critical review.Oral Oncol. 2016 Feb;53:1-9. doi: 10.1016/j.oraloncology.2015.11.012. Epub 2015 Dec 12. Oral Oncol. 2016. PMID: 26690652 Free PMC article. Review.
-
An Overview of DNA Methylation Indicators for the Course of Oral Precancer.Appl Bionics Biomech. 2022 Aug 26;2022:6468773. doi: 10.1155/2022/6468773. eCollection 2022. Appl Bionics Biomech. 2022. Retraction in: Appl Bionics Biomech. 2023 Dec 20;2023:9796101. doi: 10.1155/2023/9796101. PMID: 36060560 Free PMC article. Retracted. Review.
-
GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men.PLoS One. 2013 Dec 2;8(12):e78797. doi: 10.1371/journal.pone.0078797. eCollection 2013. PLoS One. 2013. PMID: 24312445 Free PMC article. Clinical Trial.
-
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):189-200. doi: 10.1158/1055-9965.EPI-12-1263. Epub 2012 Dec 14. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23242141 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
